Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
The mRNA therapeutics market size has grown steadily in recent years. It will grow from $33.5 billion in 2023 to $34.76 billion in 2024 at a compound annual growth rate (CAGR) of 3.8%. The mRNA therapeutics market size is expected to see steady growth in the next few years. It will grow to $40.69 billion in 2028 at a compound annual growth rate (CAGR) of 4%.
During the historic period, growth was driven by several factors including increased financial support for the development of efficient pharmaceuticals and vaccines, expansion of federal programs focused on advancing RNA-based medicines, heightened awareness of rare genetic diseases, and an increase in the number of clinical trials conducted.
In the forecast period, growth is anticipated to be driven by several factors including the rising prevalence of infectious diseases, increasing patient visits to hospitals and clinics, broader applications of mRNA therapeutics, growing demand for personalized and precision medicine, favorable regulatory environments, and accelerated approval pathways. Key trends expected in this period include advancements in mRNA delivery technologies, rapid development and adaptation of mRNA vaccines, the emergence of self-amplifying mRNA (saRNA) platforms, scalability and flexibility improvements in mRNA manufacturing, and innovations in novel mRNA modifications.
The mRNA therapeutics market is poised for growth due to the increasing prevalence of long-lasting and communicable diseases. These diseases, which endure for extended periods and can be transmitted between individuals, include conditions such as tuberculosis, HIV/AIDS, and hepatitis. Factors contributing to their rise include global travel and inadequate healthcare infrastructure, which facilitate disease spread and hinder effective management. mRNA therapeutics are pivotal in combating such diseases by swiftly enabling the body to produce proteins that enhance immune responses, thereby accelerating the development of vaccines and treatments.
Leading companies in the mRNA therapeutics market are concentrating on pioneering solutions, such as mRNA-based booster vaccines, to bolster immunity against evolving viral variants. These vaccines utilize messenger RNA (mRNA) technology to extend and enhance immunity against specific pathogens, particularly following initial vaccination series.
Messenger RNA (mRNA) therapeutics involve utilizing mRNA molecules to prompt cells to produce therapeutic proteins within the body, aimed at preventing, treating, or curing diseases by facilitating the production of specific proteins necessary for therapeutic benefits.
The primary products in mRNA therapeutics include vaccines and drugs. mRNA vaccines instruct cells via mRNA to generate proteins that stimulate an immune response against targeted diseases. These vaccines find applications across various fields such as infectious diseases, oncology, rare genetic diseases, respiratory illnesses, among others. End users include hospitals, clinics, research organizations, and other healthcare providers.
North America was the largest region in the mRNA therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.The countries covered in the mRNA therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
mRNA Therapeutics Market Competitive Landscape and Company Profiles
- Pfizer Inc.
- Overview
- Products and Services
- Strategy
- Financial Performance
- Novartis AG
- Sanofi AG
- AstraZeneca plc
- GlaxoSmithKline plc
mRNA Therapeutics Market Other Major and Innovative Companies
- Hoffmann-La Roche AG
- Moderna Therapeutics Inc
- BioNTech SE
- Vertex Pharmaceuticals Incorporated
- Catalent Inc
- Alnylam Pharmaceuticals Inc
- Sarepta Therapeutics Inc
- Arcturus Therapeutics Holdings Inc
- CureVac N.V
- Ethris GMBH
- eTheRNA immunotherapies NV
- in-Cell-Art S.a.S.
- Nutcracker Therapeutics Inc
- SCM LifeScience Co Ltd
- Suzhou Abogen Biosciences Co Ltd
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 175 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value (USD) in 2024 | $34.76 Billion |
| Forecasted Market Value (USD) by 2028 | $40.69 Billion |
| Compound Annual Growth Rate | 4.0% |
| Regions Covered | Global |
Key Topics Covered:
1. Executive Summary
2. mRNA Therapeutics Market Characteristics
3. mRNA Therapeutics Market Trends and Strategies
4. mRNA Therapeutics Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global mRNA Therapeutics Market Size and Growth
5.1. Global mRNA Therapeutics Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global mRNA Therapeutics Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global mRNA Therapeutics Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. mRNA Therapeutics Market Segmentation
6.1. Global mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Vaccines
- Drugs
6.2. Global mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Infectious Diseases
- Oncology
- Rare Genetic Diseases
- Respiratory Diseases
- Other Applications
6.3. Global mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Hospitals and Clinics
- Research Organizations
- Other End Uses
7. mRNA Therapeutics Market Regional and Country Analysis
7.1. Global mRNA Therapeutics Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global mRNA Therapeutics Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/3fmsln
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
